Trial Profile
Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients With Preexisting Renal Dysfunction Undergoing a Coronary Procedure
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 25 Mar 2014
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 25 Mar 2014 New trial record